Assetmark Inc. Buys Shares of 2,901 AdaptHealth Corp. (NASDAQ:AHCO)

Assetmark Inc. bought a new stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 2,901 shares of the company’s stock, valued at approximately $28,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Pacer Advisors Inc. acquired a new stake in shares of AdaptHealth during the 4th quarter worth about $76,271,000. Principal Financial Group Inc. boosted its stake in shares of AdaptHealth by 204.0% during the 4th quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company’s stock worth $15,735,000 after purchasing an additional 1,109,021 shares during the last quarter. State Street Corp boosted its stake in shares of AdaptHealth by 19.8% during the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock worth $46,316,000 after purchasing an additional 681,816 shares during the last quarter. FMR LLC boosted its stake in shares of AdaptHealth by 9.3% during the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company’s stock worth $82,547,000 after purchasing an additional 624,645 shares during the last quarter. Finally, Segall Bryant & Hamill LLC boosted its position in shares of AdaptHealth by 15.5% in the third quarter. Segall Bryant & Hamill LLC now owns 3,701,808 shares of the company’s stock worth $41,571,000 after acquiring an additional 496,453 shares during the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on AHCO shares. Truist Financial boosted their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. UBS Group lowered their target price on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Canaccord Genuity Group boosted their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Royal Bank of Canada boosted their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a report on Wednesday, February 26th. Finally, Robert W. Baird boosted their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $13.80.

AdaptHealth Price Performance

AHCO opened at $9.60 on Monday. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. AdaptHealth Corp. has a 52-week low of $8.35 and a 52-week high of $11.90. The company has a 50 day moving average of $10.02 and a two-hundred day moving average of $10.22. The company has a market cap of $1.29 billion, a P/E ratio of -5.82, a P/E/G ratio of 1.08 and a beta of 1.30.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.